Cogent Biosciences, Inc.
COGT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001622229
In the last 90 days, Cogent Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $7.50B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Cogent Biosciences, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 112 | 134 | +22 |
| Shares | 70.3M | 74.4M | +4.09M (+5.8%) |
| Value | $633.3M | $1.10B | +$469.8M (+74.2%) |
New holders (35)
Institutions that held Cogent Biosciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (13)
Institutions that held Cogent Biosciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Marshall Wace, LLP | 1,625,817 | $14.7M |
| Atlas Venture Associates IX, LLC | 466,832 | $4.21M |
| Millennium Management LLC | 447,634 | $4.04M |
| Pura Vida Investments, LLC | 238,787 | $2.15M |
| Polar Asset Management Partners Inc. | 235,500 | $2.12M |
| Tekla Capital Management LLC | 146,911 | $1.32M |
| Virtu Financial LLC | 30,063 | $271.0K |
| Caption Management, LLC | 23,000 | $207.0K |
| PEAK6 Investments LLC | 16,380 | $193.9K |
| Bayesian Capital Management, LP | 11,615 | $105.0K |
| Venture Visionary Partners LLC | 2,000 | $18.0K |
| ClariVest Asset Management LLC | 106 | $1.00K |
| Captrust Financial Advisors | 7 | $0 |